Table 6

Certainty of evidence (GRADE)

Certainty assessment№ of patientsEffectCertaintyImportance
No of studiesStudy designRisk of biasInconsistencyIndirectnessImprecisionOther considerationsCPAPUsual care (oxygen)Relative
(95% CI)
Absolute
(95% CI)
Death
3Randomised trialsSerious*Serious†Not seriousNot seriousNone79/1395 (5.7%)89/1550 (5.7%)RR 0.75
(0.33 to 1.72)
14 fewer per 1000
(from 38 fewer to 41 more)
⨁⨁◯◯
Low
CRITICAL
Adverse events
3Randomised trialsSerious*Serious†Not seriousNot seriousNone17/79 (21.5%)14/67 (20.8%)RR 1.52
(0.71 to 3.26)
109 more per 1000
(from 61 fewer to 472 more)
⨁⨁◯◯
Low
IMPORTANT
  • *All trials did not mask participants or personnel to the treatment intervention and no masking was conducted during outcome analyses.

  • †Point estimates vary across trials, confidence intervals with minimal overlap and tests for heterogeneity significant.

  • RR, risk ratio.